Literature DB >> 8402126

Resection for adenocarcinoma of the body and tail of the pancreas.

C D Johnson1, G Schwall, J Flechtenmacher, M Trede.   

Abstract

Adenocarcinoma of the pancreatic body and tail often presents late and is widely regarded as incurable by surgical resection; long-term survivors are rare. Thirteen patients underwent left resection (n = 7) or total pancreatectomy (n = 6) in a consecutive series of 105 patients with carcinoma of the body or tail of the pancreas. Comparison was made with 17 patients with locally advanced or metastatic disease. Preoperative computed tomography predicted irresectable disease when a large perivascular lymph node mass was demonstrated. Preoperative angiography predicted irresectable disease when there was encasement or obliteration of the coeliac axis or its major branches, or of the superior mesenteric artery or vein. Splenic vessel involvement was sometimes compatible with resection. After resection, median survival was 13 (range 3-50) months, with a minimum follow-up of 2 years. Five patients survived more than 2 years, and three are still alive 30, 43 and 50 months after resection. Resection of carcinoma of the body or tail of the pancreas was possible in 12 per cent of patients and long-term survival was observed in some of these.

Entities:  

Mesh:

Year:  1993        PMID: 8402126     DOI: 10.1002/bjs.1800800937

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  30 in total

1.  [Distal pancreatectomy with splenectomy and en bloc resection of the celiac trunk for locally advanced cancer of the pancreatic body with infiltration of the celiac trunk].

Authors:  Andreas Andreou; Matthias Glanemann; Olaf Guckelberger; Timm Denecke; Christian Grieser; Petr Podrabsky; Peter Neuhaus
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Resection of non-cystic adenocarcinoma in pancreatic body and tail.

Authors:  Hai-Chao Yan; Yu-Lian Wu; Li-Rong Chen; Shun-Liang Gao
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

4.  Management of adenocarcinoma of the body and tail of the pancreas.

Authors:  M F Brennan; R D Moccia; D Klimstra
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

5.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 6.  Controversial issues in the management of pancreatic cancer: Part Two. A debate held at St Mary's Hospital, London on 18 November 1993.

Authors:  G Glazer; C Coulter; M E Crofton; W M Gedroyc; C D Johnson; C N Mallinson; R C Russell; M L Steer; J A Summerfield; R C Williamson
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

Review 7.  Pancreatic adenocarcinoma: why and when should it be resected?

Authors:  D Ravichandran; C D Johnson
Journal:  Postgrad Med J       Date:  1997-08       Impact factor: 2.401

8.  Results of radical distal pancreatectomy with en bloc resection of the celiac artery for locally advanced cancer of the pancreatic body.

Authors:  Satoshi Kondo; Hiroyuki Katoh; Satoshi Hirano; Yoshiyasu Ambo; Eiichi Tanaka; Shunichi Okushiba; Toshiaki Morikawa
Journal:  Langenbecks Arch Surg       Date:  2003-04-05       Impact factor: 3.445

9.  Distribution and clinical significance of tumour-associated macrophages in pancreatic ductal adenocarcinoma: a retrospective analysis in China.

Authors:  S J Chen; Q B Zhang; L J Zeng; G D Lian; J J Li; C C Qian; Y Z Chen; Y T Chen; K H Huang
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

10.  Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach.

Authors:  Chang Moo Kang; Dong Hyun Kim; Woo Jung Lee
Journal:  Surg Endosc       Date:  2010-01-07       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.